Introduction
Intravenous (IV) administration of recombinant tissue plasminogen activator (rtPA) within 3 hours of symptom onset in patients with acute ischemic stroke has been proven to be an effective treatment 10) . However, IV rtPA alone is occasionally insufficient to treat severe neurological deficit due to persistent major vascular occlusion 1, 6, 8, 14) . Since early recanalization is directly correlated with functional recovery and the rate of recanalization of major arterial occlusion with IV rtPA is low 7, 8, 13) , an additional neuroendovascular approach would be a reasonable alternative for patients unresponsive to IV rtPA. In our hospital, three-dimensional computed tomography (CT) angiography is obtained before or during IV rtPA. For patients with major arterial occlusion who show no remarkable improvement of the neurological deficits after
I V r t P A , w e a g g r e s s i v e l y p e r f o r m a d d i t i o n a l neuroendovascular treatment. Soutenir (Solution, Yokohama)
is a basket-shaped microsnare which can be used to retrieve a thrombus ( Fig. 1) . Here, we report two cases of acute ischemic stroke patients who were unresponsive to rtPA and were successfully treated by thrombectomy using Soutenir.
Case 1
A 67-year-old man presented with left hemiplegia and agnosia. Since CT did not reveal any definite abnormality corresponding to the symptoms ( Fig. 2A) , IV rtPA was initiated at 110 minutes after symptom onset. The National Institutes of Health Stroke Scale (NIHSS) score at the time of infusion was 22. Although the neurological deficit slightly improved after the completion of rtPA infusion, severe hemiplegia persisted (NIHSS score; 11). Informed consent for thrombectomy was obtained from the patient's family members. The femoral artery was punctured using the •Abstract• Purpose: We report two cases of acute ischemic stroke patients treated by additional thrombectomy using a basket-shaped microsnare (Soutenir) after infusion of intravenous recombinant tissue plasminogen activator (rtPA). Successful recanalization and good prognosis were achieved in both cases. Case 1: A 67-year-old man presented with left hemiplegia and agnosia. After completion of the intravenous rtPA infusion, he continued to show severe neurological deficit. Angiography revealed occlusion of the posterior trunk and a branch of the anterior trunk of the right middle cerebral artery (MCA). The two occluded arteries were successfully recanalized by removing the clot with Soutenir, resulting in neurological improvement. Case 2: A 49-year-old man presented with right hemiplegia and aphasia. After completion of the intravenous rtPA infusion, he continued to show severe neurological deficit. Angiography revealed occlusion of the left MCA at the proximal M1 segment. The occluded artery was successfully recanalized by removing the clot in the manner described above, resulting in neurological improvement. Conclusion: To our knowledge, this is the first report describing patients treated by additional thrombectomy using a Soutenir after failed intravenous infusion of rtPA. This procedure is a therapeutic option for selected acute ischemic stroke patients who are unresponsive to intravenous rtPA.
•Key Words• acute ischemic stroke, endovascular treatment, recombinant tissue plasminogen activator, Soutenir, thrombectomy (Fig. 2D) . The retrieved clot was found at the Soutenir basket (Fig. 2E) . (Fig. 4B) . An Excelsior and a 0.016-inch GT wire were gently navigated through the MCA until they were distal to the occluded M1 segment.
Thrombectomy was performed in the same manner as described in Case 1 (Fig. 4C) . In this case, however, when (Fig. 4D) . This remaining clot was eventually removed in the same manner, and successful recanalization was finally achieved with a TIMI grade Ⅲ flow (Fig. 4E) . The patient recovered from the hemiplegia and aphasia immediately after the procedure. The procedure required 51 minutes. Although postprocedural CT disclosed a thin subarachnoid hemorrhage (SAH) in the left cerebral hemisphere (Fig. 4F) , it disappeared by the next day, and no intracerebral hemorrhage occurred. MR fluidattenuated inversion recovery image obtained on day 10
showed an area of acute infarction in the left basal ganglia and temporal lobe (Fig. 4G) . The patient was discharged with mild sensory aphasia (mRS, 2).
Discussion
Although IV rtPA within 3 hours of symptom onset has been proven to be effective 10) , it is insufficient to treat patients with severe neurological deficit due to major arterial occlusion 1, 6, 7, 8, 14) . Some previous studies of intra-arterial thrombolysis for major arterial occlusion showed that clinical outcome is highly correlated with the degree of recanalization 6, 8) . Considering that the rate of recanalization of major arterial occlusion with IV rtPA is low 6, 7, 14) , additional endovascular management in selected patients unresponsive to IV rtPA would be challenging. dimensionally configured (Fig. 1B) . Compared to a J-shaped guide wire which is two-dimensionally configured, the Sounteir is expected to remove clots more efficiently. MERCI Retriever is a helix of flexible nitinol wire, which is used for mechanical clot extraction, and is reported to be beneficial in acute ischemic stroke patients 11) . The technique of clot removal described here is similar to the techniques using the MERCI system. In contrast, the Soutenir, which has a smaller profile than that of the MERCI Retriever, is expected to capture a thrombus located more distal than M2. However, our technique of thrombectomy using the Soutenir microsnare is more dependent on the skill of the operator and is less certain to catch a clot compared with the MERCI system, which was developed exclusively for clot removal. . In that study, the rate of symptomatic cerebral hemorrhage was similar to that reported by NINDS rtPA stroke trial (6.3% vs 6.6% in NINDS) 6, 10) . However, other hemorrhagic complication including pseudoaneurysm, retroperitoneal hematoma, and groin hematoma was reported in 5 patients in the IMS study 
Conclusion
We reported two cases of acute ischemic stroke patients who were unresponsive to IV rtPA and were successfully treated by thrombectomy using a Soutenir microsnare. This technique may be promising as one of the technical options to remove a clot in patients with major arterial occlusion.
Further study with a large number of patients is required to establish the efficacy and safety of this technique.
